scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10620-009-0897-Y |
P698 | PubMed publication ID | 19582575 |
P50 | author | Gian Luca Baiocchi | Q57560505 |
P2093 | author name string | Vincenzo Villanacci | |
Elisa Rossi | |||
Federico Gheza | |||
Stefano M Giulini | |||
Nazario Portolani | |||
P2860 | cites work | Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis | Q30481528 |
Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer | Q36651751 | ||
Genetic alterations in pancreatic cancer | Q36921331 | ||
HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis | Q39754520 | ||
HER2 gene amplification and chromosome 17 copy number do not predict survival of patients with resected pancreatic adenocarcinoma | Q43455376 | ||
Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas. | Q46774145 | ||
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer | Q46942061 | ||
Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms | Q71048246 | ||
A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment | Q81511454 | ||
P433 | issue | 9 | |
P921 | main subject | adenocarcinoma | Q356033 |
P304 | page(s) | 2049-2051 | |
P577 | publication date | 2009-07-07 | |
P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
P1476 | title | HER-2/neu and topoisomerase-II-alpha expression and genic amplification in pancreatic adenocarcinoma | |
P478 | volume | 54 |
Search more.